---
$id: https://graph.org.ai/products/commodity/51281808
$type: Product
source: UNSPSC
code: "51281808"
title: "Esorubicin"
class: "51281800"
classTitle: "Anthracyclines"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Esorubicin

**UNSPSC Code**: 51281808
**Class**: [Anthracyclines](Anthracyclines.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anthracycline antibiotic with the molecular formula C27H29NO10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, RMC41L2WQ3 chemically known as 5,12-naphthacenedione, 10-((4-aminotetrahydro-6-methyl-2h-pyran-2-yl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (2s-(2.alpha,(8r*,10r*),4.beta.,6.beta))- but generally known as esorubicin, which bears US NIH Compound Identifier 44554. European Medicines Agency schedules Esorubicin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12442MIG. The term ESORUBICIN is an International Non-Proprietary Name or INN. Most nations schedule esorubicin under HS 29419000 and SITC 54139. As of Q4 2014, ESORUBICIN remains the US FDA Preferred Term for this commodity. Esorubicin bears US NLM identifiers UMLS ID C0047760 and NCI Concept Code C972. SMILES: O(C1CC(O)(CC2C1C(O)C1C(C2O)C(=O)C2C(C1=O)C(OC)CCC2)C(=O)CO)C1OC(CC(N)C1)C.

